Doping Probe Leads to Kyrgios’ Temporary Ban
The International Tennis Integrity Agency has placed a provisional ban on Nick Kyrgios following a positive test for the cocaine breakdown product benzoylecgonine. The sample was collected during the ATP 250 tournament in Mallorca on 22 June and analyzed by a WADA‑accredited laboratory, which reported the stimulant on 17 July. Cocaine is listed as a prohibited stimulant under the anti‑doping code, making its detection a violation even outside competition, though the penalty is reduced compared with in‑competition use.
Effective 4 August, the suspension prevents Kyrgios from entering any ATP, WTA, Grand Slam or national federation event, and also bars him from coaching duties. The Australian, who peaked at 13th in the world rankings in 2016, has not yet lodged an appeal against the decision. In an emotional Instagram post, Kyrgios expressed remorse, apologised to his supporters, sponsors and especially the younger fans who look up to him, and described how chronic injuries have eroded his confidence and physical capability. He pledged to stay off social platforms for 28 days to concentrate on his health and requested respect for his and his family’s privacy.
This season Kyrgios has managed only four singles matches, hampered by knee and wrist ailments that have plagued him for years. His last competitive outing was a first‑round defeat in the men’s doubles at Wimbledon, partnering Alexander Bublik. Kyrgios’ résumé includes seven ATP singles titles, a 2022 Wimbledon final loss to Novak Djokovic, and a mixed‑doubles triumph at the 2022 Australian Open with Thanasi Kokkinakis.